Gain Therapeutics, Inc. (GANX)
NASDAQ: GANX · IEX Real-Time Price · USD
2.970
+0.040 (1.37%)
At close: May 1, 2024, 4:00 PM
3.020
+0.050 (1.68%)
After-hours: May 1, 2024, 7:29 PM EDT

Gain Therapeutics Revenue

In the year 2023, Gain Therapeutics had annual revenue of $55.18K, a decrease of -60.62%.

Revenue (ttm)
$55.18K
Revenue Growth
-60.62%
P/S Ratio
873.01
Revenue / Employee
$1,903
Employees
29
Market Cap
48.17M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202355.18K-84.93K-60.62%
Dec 31, 2022140.11K-24.89K-15.08%
Dec 31, 2021164.99K136.11K471.29%
Dec 31, 202028.88K-12.42K-30.07%
Dec 31, 201941.30K20.69K100.40%
Dec 31, 201820.61K--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Cutera 230.18M
Apyx Medical 52.35M
Daxor 34.67M
Aadi Bioscience 24.35M
Milestone Scientific 9.83M
Checkpoint Therapeutics 103.00K
Revenue Rankings